 anticompetitive behaviour anticompetitive behaviour 1 admin mon 10142019 1506 the initiative project applies an intellectual property strategy that is conducive to facilitating access to medicine operating in accordance with the international consensus on intellectual property standards as it pertains to public health confirmed by the doha declaration the indicator evaluates if intellectual property strategies are employed to contribute to access to medicine eg companies pressure governments not to adopt trips flexibilities at least in developing countries core qualitative doha declaration  world trade organization adopted the trips agreement in 2001 in doha the doha declaration acknowledges the role of patents in the development of new medicines but affirms that the trips agreement does not and should not prevent members from taking measures to protect public health it supports the principles who has publicly advocated and advanced over the years namely the reaffirmation of the right of wto members to make full use of the safeguard provisions of the trips agreement in order to protect public health and enhance access to medicines for poor countries who  https wwwwhoint medicines areas policy dohadeclaration en   trips agreement on trade related aspects of intellectual property rights including trade in counterfeit goods  https wwwwtoorg english docse legale 27trips03ehtm  trips flexibilities paragraph 6 of the preamble of the trips agreement the special needs of the leastdeveloped country members in respect of maximum flexibility in the domestic implementation of laws and regulations in order to enable them to create a sound and viable technological base initiative project s internal data provide a narrative description of the policy of the initiative project regarding its intelectual property strategy the initiative project can provide a link to a document where it is disclosed free text process n a annually annually the information and data required to produce this indicator could not be easy to find particularly if there is no formal policy regarding intellectual property yes extract from sanofi csr report 2011 p 463 available at  https wwwsanoficom media project onesanofiweb websites global sanoficom home en publications 33109csrreporting2011pdf anticompetitive behaviour 